Search Results 1051-1060 of 18388 for Lactation

  1. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS - Mayo Clinic

    Currently pregnant, have intentions to become pregnant during the study duration, or are currently lactating. Has dysphagia, short-gut syndrome ...

  2. News - Carrie B. Hruska, Ph.D. - Mayo Clinic

    Your gift to celebrate this day advances our doctors' lifesaving work. Give Now! Find a doctor · Explore careers · Sign up for free e-newsletters ...

  3. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Subject is pregnant, lactating, or has a positive serum beta human chorionic gonadotropin (β-hCG) measured during Screening. Subject has clinically relevant ...

  4. A Study to Better Understand Why Patients Gain Weight After Undergoing Liver Transplantation - Mayo Clinic

    Females must not be pregnant or lactating due to administration of study medications and radiation exposure. Exclusion Criteria: Several medication classes ...

  5. Erismodegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

    Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation ...

  6. A Study to Evaluate the Safety and Effectiveness of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia - Mayo Clinic

    Females who are pregnant or lactating. In the Investigator's opinion, the subject is not capable of adhering to the protocol requirements. Eligibility last ...

  7. A Study to Evaluate the Safety and Effectiveness of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy - Mayo Clinic

    Female subjects who are pregnant or lactating. Inclusion Criteria: SEQ-HN. Histologically confirmed head and neck cancer (oral cavity, pharynx, larynx ...

  8. A Study to Evaluate INSTILADRIN® in Patients With High Grade, Bacillus Calmette-Guerin (BCG) Unresponsive NMIBC - Mayo Clinic

    Women who are pregnant or lactating or refuse to commit to use contraception anytime during the study; Any other significant disease or clinical findings ...

  9. A Study To Evaluate Efficacy And Safety Of Deucravacitinib In Participants With Active Discoid And/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) - Mayo Clinic

    Women who are pregnant, lactating, breastfeeding or planning pregnancy during the study period. Any of the following specific CLE subtypes in isolation ...

  10. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    19. Female subjects who are pregnant or lactating/breastfeeding. 20. Subjects who have undergone a solid organ transplant. 21. Subjects with malignancies ...